LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 128 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $912,070 | – | 542,899 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $46,410,000 | 99.99% |
| Artal Group S.A. | 57,517,978 | $617,743,000 | 13.80% |
| ACUTA CAPITAL PARTNERS, LLC | 400,000 | $4,296,000 | 2.49% |
| BRIDGER MANAGEMENT, LLC | 1,292,368 | $13,880,000 | 0.95% |
| Rhenman & Partners Asset Management AB | 200,000 | $2,148,000 | 0.34% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 525,000 | $5,639,000 | 0.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 400,000 | $4,296,000 | 0.21% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $384,000 | 0.19% |
| MASTERS CAPITAL MANAGEMENT LLC | 500,000 | $5,370,000 | 0.18% |
| Round Table Services, LLC | 21,611 | $232,000 | 0.17% |